Pfizer posts a single-digit gain
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Better sales in the US and in its International segment helped to push up Pfizer’s Consumer Healthcare turnover by 7% to US$905 million (€754 million) in the first quarter of 2018.